HHS audit finds hospitals overbill for IMRT planning
August 22, 2018 -- The Medicare system overpaid U.S. hospitals by nearly $26 million for intensity-modulated radiation therapy (IMRT) planning services, according to an audit released by the Office of Inspector General at the U.S. Department of Health and Human Services (HHS).  Discuss
Alpha Tau prepares clinical trials for Alpha DaRT
August 21, 2018 -- Israeli radiation therapy technology developer Alpha Tau Medical said that its Alpha Diffusing Alpha-Emitters Radiation Therapy (DaRT) system has received the necessary regulatory approvals to be used in clinical trials at U.S. cancer centers.
ASRT announces vacancy rates, awards grants
August 20, 2018 -- The American Society of Radiologic Technologists (ASRT) announced that vacancy rates for radiation therapists rose in 2018, and it also awarded two safety grants.
Accuray posts revenue increases for Q4, fiscal 2018
August 17, 2018 -- Radiation oncology firm Accuray posted revenue increases and a lower net loss for its fourth quarter and fiscal 2018.
NYSE American delivers noncompliance notice to Navidea
August 16, 2018 -- Radiopharmaceutical developer Navidea Biopharmaceuticals has received a notice from the New York Stock Exchange (NYSE) American stating that the company's stock does not comply with the exchange's listing requirements.
International Isotopes posts healthy Q2 results
August 15, 2018 -- Radioisotope manufacturer International Isotopes posted revenue gains and a lower net loss for its second quarter and first six months of 2018.
ViewRay announces $150M stock offering
August 15, 2018 -- Image-guided radiation therapy developer ViewRay has announced an underwritten public offering of 1.6 million shares of common stock at $9.25 per share.
AI can optimize treatment of glioblastoma
August 14, 2018 -- An artificial intelligence (AI) algorithm can reduce dosing levels for chemotherapy and radiotherapy for glioblastoma without affecting the effectiveness of the treatments, according to a study being presented this week at the 2018 Machine Learning for Healthcare conference at Stanford University.  Discuss
Is radiation therapy warranted for DCIS postlumpectomy?
August 10, 2018 -- Researchers have found that radiation therapy after lumpectomy in women with ductal carcinoma in situ (DCIS) reduces cumulative breast cancer mortality rates by 25%, compared with treatments that do not include radiation. The results were published online August 10 in JAMA Network Open.  Discuss
Special Feature
IMV: Imaging boosts precision in radiation therapy

Radiation therapy is a relatively stable market, with procedure volume growing at an average annual rate of 2%. But major technological changes in radiation oncology are brewing under the surface, according to a new report by IMV Medical Information Division. Read more